PURE BIOSCIENCE, INC. | 2013 | FY | 3


 

 

 

 

 

 

 

 

 

 

 

 

 

July 31,

 

2013

 

2012

Net operating loss carry-forward

$

22,482,000 

 

$

20,677,000 

Stock options and warrants

 

1,915,000 

 

 

1,765,000 

Other temporary differences

 

252,000 

 

 

118,000 

Total deferred tax assets

 

24,649,000 

 

 

22,560,000 

Valuation allowance for deferred tax assets

 

(24,649,000)

 

 

(22,560,000)

Net deferred tax assets

$

 

$

 


us-gaap:SummaryOfDeferredTaxLiabilityNotRecognizedTextBlock